Covered recipient · General Payments record
RAYMOND BENJAMIN RAVEN
Allopathic & Osteopathic Physicians Orthopaedic Surgery Hand Surgery
General Payments · PY2018–2024
$322,339.32
- Reported across 122 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Royalty or License | $40,742.22 | 15 |
| Food and Beverage | $41.23 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ACUMED LLC | $40,742.22 | 15 |
| Endo USA, Inc. | $26.30 | 1 |
| Abbott Laboratories | $14.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.93 | 09/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125343235 | CMS |
| ACUMED LLC | $1,879.50 | 01/18/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125007592 | CMS |
| ACUMED LLC | $6,172.34 | 01/18/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125007674 | CMS |
| ACUMED LLC | $531.30 | 01/18/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125007684 | CMS |
| ACUMED LLC | $3,120.93 | 04/29/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125007662 | CMS |
| ACUMED LLC | $5,764.49 | 04/29/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125021575 | CMS |
| ACUMED LLC | $1,513.04 | 04/29/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125021582 | CMS |
| ACUMED LLC | $2,342.94 | 07/31/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125007582 | CMS |
| ACUMED LLC | $6,255.71 | 07/31/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125007603 | CMS |
| ACUMED LLC | $1,402.64 | 07/31/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125007612 | CMS |
| ACUMED LLC | $1,925.92 | 10/30/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125007624 | CMS |
| ACUMED LLC | $329.45 | 10/30/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125007634 | CMS |
| ACUMED LLC | $6,118.41 | 10/30/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125007644 | CMS |
| ACUMED LLC | $995.70 | 10/30/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125007653 | CMS |
| ACUMED LLC | $1,684.76 | 10/30/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125021588 | CMS |
| ACUMED LLC | $705.09 | 10/30/2024 | Royalty or License | Undisputed | 01/23/2026 | 1125021593 | CMS |
| Endo USA, Inc. | $26.30 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138586682 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.